Cyteir Therapeutics Inc (CYT) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cyteir Therapeutics Inc   (NASDAQ: CYT)


Cyteir Therapeutics Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cyteir Therapeutics Inc's ROI in the third quarter of 2023?
Cyteir Therapeutics Inc recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -24.8%.

Within the Healthcare sector 383 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 3570, from total ROI ranking in the second quarter of 2023 at 3648.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -21.95 % -22.29 % -20.21 % 10.38 % -75.96 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 125 128 135 148 156
Return On Investment (TTM) -24.8 % -28.75 % -29.4 % -28.5 % -28.6 %
CYT's Overall Ranking # 3570 # 3648 # 3700 # 3909 # 0
Seq. Investment Change TTM -5.44 % -6.29 % -6.46 % -5.82 % -5.86 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -33 -41 -44 -46 -49

CYT Company Profile >> Back to CYT Roi Comparisons >> See Annual CYT Return On Investment



Return On Investment CYT's Ranking
Within: No.
Industry # 146
Sector # 384
Overall # 3570

Return On Investment Statistics
High Average Low
9.41 %
-10.53 %
-67.54 %
(Sep 30 2014)   (Sep 30 2022)







Financial Statements
Cyteir Therapeutics Inc's III. Quarter Investments $ 125 Millions CYT's Balance sheet
Cyteir Therapeutics Inc's III. Quarter Income $ -4 Millions Quarterly CYT's Income Statement
CYT's Income by Division See CYT's Income by Division


CYT Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012
Total Investments in Millions 148 188 2,400 2,312 3,120
Y / Y Investment Growth -21.27 % -92.17 % 3.82 % -25.9 % 3.26 %
Net Income in Millions -46 -42 154 174 190
Y / Y Net Income Growth - - -11.56 % -8.52 % -9.86 %
Annual Return On Investment -31.14 % -22.42 % 6.41 % 7.52 % 6.09 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CYT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CYT's Competitors
Subscribers only: Roi for Cyteir Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CYT's Customers

Other Ratios
CYT's Roa CYT's Inventory Turnover Ratio CYT's Growth Rates CYT's Dividend Statistics
CYT's Profitability Ratios CYT's Asset Turnover Ratio CYT's Dividend Growth
CYT's Roe CYT's Valuation Ratios CYT's Financial Strength Ratios CYT's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.